NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

9480	Companies
185535	Keywords
117927	Articles
99378	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 12/17/2024 at 22:15, 11 months 18 days ago

NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
Nanobiotix announces virtual event 'Accelerating the Future of Nanotherapeutics' on December 19, 2024, showcasing Curadigm Nanoprimer Platform for drug development

Virtual Event NANOBIOTIX Curadigm Nanotherapeutics Nanoprimer
BRIEF

published on 12/09/2024 at 22:20, 11 months 26 days ago

Nanobiotix conclut avec succès une étude de phase 1 sur le cancer du pancréas

FDA Étude De Phase 1 Cancer Du Pancréas Chimiothérapie Radiothérapie
BRIEF

published on 12/09/2024 at 22:20, 11 months 26 days ago

Nanobiotix successfully completes phase 1 study in pancreatic cancer

FDA Pancreatic Cancer Chemotherapy Phase 1 Study Radiotherapy
PRESS RELEASE

published on 12/09/2024 at 22:15, 11 months 26 days ago

NANOBIOTIX annonce l’achèvement de l’étude de phase 1 avec NBTXR3 (JNJ-1900) dans le cancer du pancréas
Nanobiotix annonce l'achèvement de l'étude de Phase 1 avec NBTXR3 dans le cancer du pancréas, avec des résultats encourageants. Un essai randomisé est prévu. Plus d'informations sur www.nanobiotix.com

Étude De Phase 1 Cancer Du Pancréas NANOBIOTIX NBTXR3 Essai Randomisé
PRESS RELEASE

published on 12/09/2024 at 22:15, 11 months 26 days ago

NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
Nanobiotix completes Phase 1 study of NBTXR3 in pancreatic cancer, showing promising outcomes & safety profile. FDA approves new trial. Full data to be shared in 2025

FDA Approval Pancreatic Cancer NANOBIOTIX NBTXR3 Phase 1 Study
BRIEF

published on 11/25/2024 at 09:53, 1 year ago

Franchissement de Seuil par Baillie Gifford chez Nanobiotix

Capital Droits De Vote Franchissement De Seuil NANOBIOTIX Baillie Gifford
BRIEF

published on 11/25/2024 at 09:53, 1 year ago

Threshold Crossing by Baillie Gifford at Nanobiotix

Voting Rights Capital Threshold Crossing NANOBIOTIX Baillie Gifford
PRESS RELEASE

published on 11/25/2024 at 09:48, 1 year ago

Franchissement de seuil
Déclaration de franchissement de seuil par Baillie Gifford & Co. pour NANOBIOTIX le 19 novembre 2024

Franchissement De Seuil NANOBIOTIX Baillie Gifford & Co.
BRIEF

published on 10/31/2024 at 08:35, 1 year 1 month ago

NANOBIOTIX to Participate in Investor Conferences in November

Innovation Investors Healthcare Conférences NANOBIOTIX
BRIEF

published on 10/31/2024 at 08:35, 1 year 1 month ago

NANOBIOTIX participera aux conférences investisseurs en novembre

Innovation Conférences Investisseurs Soins De Santé NANOBIOTIX

Accesswire

Published on 12/05/2025 at 19:50, 7 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 37 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 12 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 37 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 57 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 58 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 1 hour 30 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 41 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 2 hours 5 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 2 hours 10 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 39 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 39 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 46 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 46 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 58 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE